GX-G3, a long-acting G-CSF, compared with pegfilgrastim in reducing duration of severe neutropenia after chemotherapy for non-Hodgkin's lymphoma. için istatistikler
Toplam ziyaret
views | |
---|---|
GX-G3, a long-acting G-CSF, compared with pegfilgrastim in reducing duration of severe neutropenia after chemotherapy for non-Hodgkin's lymphoma. | 0 |
Aylık toplam ziyaret
views | |
---|---|
Haziran 2024 | 0 |
Temmuz 2024 | 0 |
Ağustos 2024 | 0 |
Eylül 2024 | 0 |
Ekim 2024 | 0 |
Kasım 2024 | 0 |
Aralık 2024 | 0 |